ARCHIVES

Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion

This article is from The Cancer Letter archive.

Vol. 04 No. 44 | November 3, 1978

Download PDF Visit The Full Archive

Related Articles

ACS Study Finds Low Tar Cigarettes Cause Few Lung Abnormalities

March 2, 1979

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

June 30, 2000

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009